Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARES: Asenapine vs Olanzapine Extension in Acute Mania
NCT00143182Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jan 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 3, double-blind trial of asenapine in bipolar disorder (BD) (2 arms), sponsored by Organon & Co. Primary endpoint: Young Mania Rating Scale at 9 weeks. Started Jan 2005; status: completed.
02
Drugs
asenapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00143182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143182.